Denmark· DK-28105008812
Spirocort Turbuhaler
A budesonide product containing budesonid, registered in Denmark by Abacus Medicine A/S. The same ATC class is registered in 15 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Budesonide is registered in 15 of 19 countries.
Countries holding a registration under ATC R03BA02 (budesonide), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 9 of them publish a price we can compare per daily dose
Budesonide · ATC R03BA02
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- BUDESONID
- Manufacturer
- Abacus Medicine A/S
- Country
- Denmark (DK)
- ATC code
- R03BA02
- ATC class
- Budesonide
- Defined daily dose
- 0.8 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105008812
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
686 interactions on record for budesonide.
Graded by severity as the source publishes them — 62 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Budesonide · interactions on record
686 records
- 62 severe
- 260 moderate
- 27 minor
- 337 info
Most severe, free to view
- LonafarnibA16AX20severe
- ConivaptanC03XA02severe
- Bempedoic acidC10AX15severe
- MifepristoneG03XB01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under R03BA02
Budesonide, as other registers publish it.
- ItalyAIRCORTITALCHIMICI S.P.A.
- ItalyAIRCORTITALCHIMICI S.P.A.
- PolandBDS NAurovitas Pharma Polska Sp. z o.o.
- PolandBDS NAurovitas Pharma Polska Sp. z o.o.
- PolandBDS NAurovitas Pharma Polska Sp. z o.o.
- PolandBenodilZakłady Farmaceutyczne POLPHARMA S.A.
- PolandBenodilZakłady Farmaceutyczne POLPHARMA S.A.
- PolandBenodilZakłady Farmaceutyczne POLPHARMA S.A.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fe24cd2f-0e06-448b-9b3b-ebc11d04884a GET /v1/drugs/fe24cd2f-0e06-448b-9b3b-ebc11d04884a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "inhalationspulver",
"source": "dkma",
"strength": "200 mikrogram/dosis",
"auth_role": "DKMA",
"dk_drugid": "28105008812",
"substance": "BUDESONID",
"auth_procedure": "Par-Imp",
"in_medicinpriser": true,
"registration_date_serial": "40956"
}See everything about budesonide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.